TMEM132A promotes cervical cancer progression via HOMER3-mediated activation of FAK/PI3K/AKT signaling pathway
Fengyi Sun, Zhe Wang · 2026
Read TMEM132A promotes cervical cancer progression via HOMER3-mediated activation of FAK/PI3K/AKT signaling pathway by Fengyi Sun, Zhe Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13507356.txt.
Description
Fengyi Sun and Zhe Wang identify, in 2026 work, the membrane protein TMEM132A as a driver of cervical cancer growth acting through a scaffold partner called HOMER3. Cervical cancer still kills some 340,000 women yearly, and advanced disease resists current therapy. Database mining plus lab validation showed TMEM132A overproduced in tumors and cell lines, matching aggressive features.
Extra TMEM132A sped cell growth, migration, invasion, and entry into the DNA-copying phase, while silencing it reversed those gains. The protein raises HOMER3 levels, which switch on the FAK, PI3K, and AKT growth relay. Silencing HOMER3 erased the cancer-promoting effects. TMEM132A enters the list of candidate markers and drug targets for this cancer.
Catalog record
| CREATOR | Fengyi Sun, Zhe Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42659 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |